New Delhi: India has made significant strides in domestic manufacturing of active pharmaceutical ingredients (APIs), with investments of ₹4,763.34 crore under the Promotion of Bulk Drug Parks scheme ...
WASHINGTON, Dec 1 (Reuters) - U.S. manufacturing contracted for the ninth straight month in November, with factories facing slumping orders and higher prices for inputs as the drag from import tariffs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback